UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 172

Sortiert nach

Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10 418 British women aged 54-65

BJOG : an international journal of obstetrics and gynaecology, 2012-01, Vol.119 (1), p.40-50

2012

Link zum Volltext

Verfügbarkeit prüfen

Systematic review of the use of translated patient-reported outcome measures in cancer trials

Trials, 2021-04, Vol.22 (1), p.306-306, Article 306

2021

Link zum Volltext

Verfügbarkeit prüfen

Attitudes, challenges and needs about diet and physical activity in endometrial cancer survivors: a qualitative study

European journal of cancer care, 2017-11, Vol.26 (6), p.e12531-n/a

2017

Link zum Volltext

Verfügbarkeit prüfen

Influences on multidisciplinary team decision‐making

International journal of gynecological cancer, 2008-03, Vol.18 (2), p.215-222

2008

Link zum Volltext

Verfügbarkeit prüfen

Moving towards population‐based genetic risk prediction for ovarian cancer

BJOG : an international journal of obstetrics and gynaecology, 2017-05, Vol.124 (6), p.855-858

2017

Link zum Volltext

Verfügbarkeit prüfen

Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening

Climacteric : the journal of the International Menopause Society, 2017-06, Vol.20 (3), p.240-247

2017

Link zum Volltext

Verfügbarkeit prüfen

Population-Based, Risk-Stratified Genetic Testing for Ovarian Cancer Risk: A Focus Group Study

Public health genomics, 2013-01, Vol.16 (4), p.184-191

2013

Link zum Volltext

Verfügbarkeit prüfen

Quality of Life in the ICON7 GCIG Phase III Randomised Clinical Trial

European journal of cancer (1990), 2011, Vol.47, p.12-12

2011

Link zum Volltext

Verfügbarkeit prüfen

Obesity, Diet, Physical Activity, and Health-Related Quality of Life in Endometrial Cancer Survivors

Nutrition reviews, 2015-06, Vol.73 (6), p.399-408

2015

Link zum Volltext

Verfügbarkeit prüfen

Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer

Gynecologic oncology, 2024-06, Vol.185, p.128-137

2024

Link zum Volltext

Verfügbarkeit prüfen

Cancer information and support needs of statutory and voluntary sector staff working with people from ethnically diverse communities

European journal of cancer care, 2007-03, Vol.16 (2), p.122-129

2007

Link zum Volltext

Verfügbarkeit prüfen

Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study

International journal of gynecological cancer, 2022-06, Vol.32 (6), p.761-768

2022

Link zum Volltext

Verfügbarkeit prüfen

Sensitivity to change of the EORTC quality of life module measuring cancer‐related fatigue (EORTC QlQ‐Fa12): Results from the international psychometric validation

Psycho-oncology (Chichester, England), 2019-08, Vol.28 (8), p.1753-1761

2019

Link zum Volltext

Verfügbarkeit prüfen

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study

The oncologist (Dayton, Ohio), 2017-09, Vol.22 (9), p.1117-1124

2017

Link zum Volltext

Verfügbarkeit prüfen

How long have we got? The accuracy of physicians’ estimates and scenarios for survival time in 898 women with recurrent ovarian cancer (ROC)

JOURNAL OF CLINICAL ONCOLOGY, 2019, Vol.37 (15_suppl), p.5549-5549

2019

Link zum Volltext

Verfügbarkeit prüfen

Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)

European journal of cancer (1990), 2011-01, Vol.47 (2), p.183-190

2011

Link zum Volltext

Verfügbarkeit prüfen

0734: Gynaecological Oncology Nursing its Underbelly Revealed

International journal of gynecological cancer, 2006-10, Vol.16 (Suppl 3), p.806-806

Lanceley, A

2006

Link zum Volltext

Verfügbarkeit prüfen

THE MULTIDISCIPLINARY TEAM MEETING: AN ETHNO GRAPHIC STUDY

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.206-206

2004

Link zum Volltext

Verfügbarkeit prüfen

Baseline quality of life (QOL) as a predictor of stopping chemotherapy early, and of overall survival, in platinum-resistant/refractory ovarian cancer (PRROC): The GCIG symptom benefit study (SBS)

JOURNAL OF CLINICAL ONCOLOGY, 2016, Vol.34 (15_suppl), p.5508-5508

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 172

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(129)
Mit Volltextzugriff
(142)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(172)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

Science & Technology
(95)
Life Sciences & Biomedicine
(92)
Humans
(75)
Female
(54)
Adult
(36)
Oncology
(36)
Cancer
(35)
Middle Aged
(29)
Aged
(26)
Quality Of Life
(26)
Obstetrics & Gynecology
(25)
Patients
(24)
Ovarian Cancer
(21)
Public, Environmental & Occupational Health
(18)
Social Sciences
(17)
Qualitative Research
(16)
Male
(15)
Midwifery
(15)
Surveys And Questionnaires
(15)
General & Internal Medicine
(14)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Prevalence, frequency and problem rating of hot flushes persist in older postmenopausal women: impact of age, body mass index, hysterectomy, hormone therapy use, lifestyle and mood in a cross-sectional cohort study of 10 418 British women aged 54-65

Systematic review of the use of translated patient-reported outcome measures in cancer trials

Attitudes, challenges and needs about diet and physical activity in endometrial cancer survivors: a qualitative study

Influences on multidisciplinary team decision‐making

Moving towards population‐based genetic risk prediction for ovarian cancer

Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG symptom benefit study (SBS)

Prevalence and predictors of complementary and alternative medicine/non-pharmacological interventions use for menopausal symptoms within the UK Collaborative Trial of Ovarian Cancer Screening

Population-Based, Risk-Stratified Genetic Testing for Ovarian Cancer Risk: A Focus Group Study

Quality of Life in the ICON7 GCIG Phase III Randomised Clinical Trial

Obesity, Diet, Physical Activity, and Health-Related Quality of Life in Endometrial Cancer Survivors

Hidden in plain sight – Survival consequences of baseline symptom burden in women with recurrent ovarian cancer

Cancer information and support needs of statutory and voluntary sector staff working with people from ethnically diverse communities

Validation of the modified Glasgow Prognostic Score (mGPS) in recurrent ovarian cancer (ROC) – Analysis of patients enrolled in the GCIG Symptom Benefit Study (SBS)

Symptom burden and quality of life with chemotherapy for recurrent ovarian cancer: the Gynecologic Cancer InterGroup-Symptom Benefit Study

Measure of Ovarian Symptoms and Treatment concerns (MOST) indexes and their associations with health-related quality of life in recurrent ovarian cancer

Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancer

Sensitivity to change of the EORTC quality of life module measuring cancer‐related fatigue (EORTC QlQ‐Fa12): Results from the international psychometric validation

Reducing Uncertainty: Predictors of Stopping Chemotherapy Early and Shortened Survival Time in Platinum Resistant/Refractory Ovarian Cancer—The GCIG Symptom Benefit Study

How long have we got? The accuracy of physicians’ estimates and scenarios for survival time in 898 women with recurrent ovarian cancer (ROC)

Psychometric validation of the European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Endometrial Cancer Module (EORTC QLQ-EN24)

0734: Gynaecological Oncology Nursing its Underbelly Revealed

THE MULTIDISCIPLINARY TEAM MEETING: AN ETHNO GRAPHIC STUDY

Predictors of stopping chemotherapy early and short survival in patients with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) who have had ≥3 lines of prior chemotherapy: The GCIG symptom benefit study (SBS)

Baseline quality of life (QOL) as a predictor of stopping chemotherapy early, and of overall survival, in platinum-resistant/refractory ovarian cancer (PRROC): The GCIG symptom benefit study (SBS)

Suchergebnisse filtern